摘要 : Adoptive cell therapy(ACT)has emerged with remarkable efficacies for tumor immunotherapy.Chimeric antigen receptor(CAR)T cell therapy,as one of most promising ACTs,has achieved prominent effects in treating malignant hematological... 展开
作者 | Yue Liu Lingna An Chengfei Yang Xiaoqi Wang Ruihao Huang Xi Zhang |
---|---|
作者单位 | |
期刊名称 | 《血液科学(英文)》 |
页码/总页数 | P.170-179 / 10 |
语种/中图分类号 | 汉语 / R28 |
关键词 | Anti-tumor efficacy Adoptive cell therapy CAR-T Ginsenoside Rg1 Metabolic regulation |
DOI | 10.1097/BS9.0000000000000165 |
基金项目 | supported by the National Natural Science Foundation of China(No.82020108004 and 81873424);the Natural Science Foundation of Chongqing,China(No.CSTB2022NSCQ-MSX1287);Special Funding for the Frontiers of Military Medical Basics(No.2018YQYLY002);Key Technical Innovation Projects in Clinical Fields of Xinqiao Hospital(No.2018JSLC0020);the Young Doctor Talent Incubation Program of Xinqiao Hospital(No.2022YQB016). |